Pharmacotherapeutic approaches for transportation of anticancer agents via skin

References

• Croce CM. Oncogenes and cancer. N Engl J Med. 2008;358:502–511.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Müller-Hermelink N, Braumüller H, Pichler B. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis . Cancer Cell. 2008;13:507–518.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–322.
   PubMed Web of Science ®Google Scholar
• Sibbesen NA, Kopp KL, Litvinov IV. Jak3: STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma. Oncotarget 2015;6:20555–20569.
   PubMed Web of Science ®Google Scholar
• Nicolaidou V, Koufaris C. MicroRNA responses to environmental liver carcinogens: biological and clinical significance. Clin Chim Acta. 2015;445:25–33.
   PubMed Web of Science ®Google Scholar
• Yin WY, Lee MC, Lai NS. BK virus as a potential oncovirus for bladder cancer in a renal transplant patient. J Formos Med Assoc. 2015;114:373–374.
   PubMed Web of Science ®Google Scholar
• Pluchino LA, Liu AKY, Wang HCR. Reactive oxygen species-mediated breast cell carcinogenesis enhanced by multiple carcinogens and intervened by dietary ergosterol and mimosine. Free Radic Biol Med. 2015;80:12–26.
   PubMed Web of Science ®Google Scholar
• Labala S, Jose A, Venuganti VVK. Transcutaneous iontophoretic delivery of STAT3 siRNA using layer-by-layer chitosan coated gold nanoparticles to treat melanoma. Colloids Surf Biointerfaces. 2016;146:188–197.
   PubMed Web of Science ®Google Scholar
• Walker S, Brew B. Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis. J Clin Neurosci. 2016;31:217–218.
   PubMed Web of Science ®Google Scholar
• Shankar DB, Cheng JC, Kinjo K. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 2005;7:351–362.[10.1016/j.ccr.2005.02.018]
   PubMed Web of Science ®Google Scholar
• Kim H, Lee C, Yang JS. Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia. Eur J Med Chem. 2016;120:74–85.
   PubMed Web of Science ®Google Scholar
• Beil CM, Keberle M. Oral and oropharyngeal tumors. Eur J Radiol. 2008;66:448–459.
   PubMed Web of Science ®Google Scholar
• Adegboyega PA, Rodriguez S, McLarty J. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma. Hum Pathol. 2010;41:1128–1137.
   PubMed Web of Science ®Google Scholar
• Lucena SR, Salazar N, Gracia-Cazana T. Combined treatments with photodynamic therapy for non-Melanoma skin cancer. Int J Mol Sci. 2015;16:25912–25933.
   PubMed Web of Science ®Google Scholar
• Hodi FS, Corless CL, Giobbie-Hurder A. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal: acral, and chronically sun-damaged skin. Jco. 2013;31:3182–3190.
   PubMed Web of Science ®Google Scholar
• Li C, Tang C, Hu Z. Synthesis and structure–activity relationships of novel hybrid ferrocenyl compounds based on a bicyclic core skeleton for breast cancer therapy. Bioorg Med Chem. 2016;24:3062–3074.
   PubMed Web of Science ®Google Scholar
• Simões MCF, Sousa JJS, Pais AACC. Skin cancer and new treatment perspectives: a review. Cancer Lett. 2015;357:8–42.
   PubMed Web of Science ®Google Scholar
• Hasby EA, Mashad NE, Eltatawy R. C-Kit, CD34 & a-SMA immunohistochemical features in classic kaposi sarcoma and kaposiform hemangioendothelioma. J Microsc Ultrastruct. 2017;5:49–57.
   PubMedGoogle Scholar
• Crowell HL, MacLean AL, Stumpf MPH. Feedback mechanisms control coexistence in a stem cell model of acute myeloid leukaemia. J Theor Biol. 2016;401:43–53.
   PubMed Web of Science ®Google Scholar
• Taveira SF, Lopez RFV. Topical administration of anticancer drugs for skin cancer treatment. In Skin Cancers-Risk Factors, Prevention and Therapy. IntechOpen, Croatia: Skin Cancers Caterina La Porta; 2011.
   Google Scholar
• McGrath JA, Eady RAJ, Pope FM. Anatomy and organization of human skin. Rook’s Textbook of Dermatology. United States: Blackwell Science Ltd; 2004. p.1–15.
   Google Scholar
• VA, Neel AJ. Sober. Other Skin Cancers. In: Donald W. Kufe, Raphael E. Pollock, Ralph R, et al., editors. Cancer Medicine Volume 7.Colombia:DC Decker; 2006. p.1663–1674.
   Google Scholar
• Schäfer-Korting MA, Wolfgang MB, Korting H. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427–443.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603–618.
   PubMed Web of Science ®Google Scholar
• Schmid M-H, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev. 1996;18:335–342.
   Web of Science ®Google Scholar
• Rancan F, Papakostas D, Hadam S. Investigation of polylactic acid (PLA) nanoparticles as drug delivery systems for local dermatotherapy. Pharm Res. 2009;26:2027–2036.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Lopez RFV. Current efforts and the potential of nanomedicine in treating fungal keratitis. Expert Rev Ophthalmol. 2010;5:365–384.
   Google Scholar
• Teixeira Z, Zanchetta B, Melo BA, et al. Retinyl palmitateflexible polymeric nanocapsules: characterization and permeation studies. Colloids Surf B: Biointerfaces. 2010;81:374–380.
   PubMed Web of Science ®Google Scholar
• Marquele-Oliveira F, Santana DCA, Taveira SF. Development of nitrosyl ruthenium complexloaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation. J Pharm Biomed Anal. 2010;53:843–851.
   PubMed Web of Science ®Google Scholar
• Donnelly RF, McCarron P, Al-Kassas R, et al. Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles. Biopharm Drug Dispos. 2009;30:55–70.
   PubMed Web of Science ®Google Scholar
• McCarron PA, Hall M. Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly (lactide-co-glycolide) nanoparticles. Int J Pharm. 2008;348:115–124.
   PubMed Web of Science ®Google Scholar
• Garg NK, Tyagi RK, Singh B. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-kB and FOXO1. Int. J. Pharm 2016;499:301–320.
   PubMed Web of Science ®Google Scholar
• Bhatnagar P, Pant AB, Shukla Y. Bromelain nanoparticles protect against 7,12-dimethylbenz[a]anthracene induced skin carcinogenesis in mouse model. Eur J Pharm Biopharm. 2015;91:35–46.
   PubMed Web of Science ®Google Scholar
• Pierre MBR, Ricci E, Tedesco AC. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res 2006;23:360–366.
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Muzzalupo R. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm. 2008;353:233–242. 2008),
   PubMed Web of Science ®Google Scholar
• Liu CH, Chang FY. Development and characterization of eucalyptol microemulsions for topic delivery of curcumin. Chem Pharm Bull. 2011;59:172–178.
   PubMed Web of Science ®Google Scholar
• Collaud S, Peng Q, Gurny R, et al. Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix. J Pharm Sci. 2008;97:2680–2690.
   PubMed Web of Science ®Google Scholar
• Kong BJ, Kim A, Park SN. Properties and in vitro drug release of hyaluronic acid-hydroxyethyl cellulose hydrogels for transdermal delivery of isoliquiritigenin. Carbohydr Polym. 2016;147:473–481.
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang X, Gou M. A novel transdermal honokiol formulation based on Pluronic F127 copolymer. Drug Deliv. 2010;17:138–144.
   PubMed Web of Science ®Google Scholar
• Benson HA. Transdermal drug delivery: penetration enhancement techniques. Cdd. 2005;2:23–33..
   PubMedGoogle Scholar
• Momparler RL. Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia. Exp Hematol Oncol. 2013;2:20.
   PubMedGoogle Scholar
• Ruan R, Chen M, Sun S. Topical and targeted delivery of siRNAs to melanoma cells using a fusion peptide carrier. Sci Rep. 2016;6:29159.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Lopez RFV. Basic principles and applications of iontophoresis for cutaneous penetration of drugs. Quím Nova. 2008;31:1490–1498.
   Web of Science ®Google Scholar
• Gelfuso GM, Gelfuso Gratieri T, Souza JG, Thomazine. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. Eur J Pharm Biopharm. 2011;77:249–256.
   PubMed Web of Science ®Google Scholar
• Charoo NA, Rahman Z, Repka MA. Electroporation: An avenue for transdermal drug delivery. Curr Drug Deliv. 2010;7:125–136.
   PubMedGoogle Scholar
• Murthy SN, Murthy Zhao Y–L, Sen A, Hui. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. J Control Release. 2004;99:393–402.
   PubMed Web of Science ®Google Scholar
• K Moser Kriwet K, Naik A, Kalia. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm. 2001;52:103–112.
   PubMed Web of Science ®Google Scholar
• Shende PK, Bakal RL, Gaud RS. Modulation of serratiopeptidase transdermal patch by lipid-based transfersomes. J Adhes Sci Technol. 2015;29:2622–2633.
   Web of Science ®Google Scholar
• Priya P, Raj RM, Vasanthakumar V. Curcumin-loaded layer-by-layer folic acid and casein coated carboxymethyl cellulose/casein nanogels for treatment of skin cancer. Arab J Chem. 2017;22. Available from: https://doi.org/10.1016/j.arabjc.2017.07.010
   Google Scholar
• Yang J, Hu J, He B. Transdermal delivery of therapeutic agents using dendrimers (US20140018435A1): a patent evaluation. Expert Opin Ther Pat.2015;325:1209–1214.
   Web of Science ®Google Scholar
• Rouanet P, Linares-Cruz G, Dravet F. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen. JCO. 2005;123:2980–2987.
   Web of Science ®Google Scholar
• Shende P, Sardesai M, Gaud RS. Micro to nanoneedles: a trend of modernized transepidermal drug delivery system. Artif Cells Nanomed Biotechnol. 2018;46:19–25.
   PubMed Web of Science ®Google Scholar
• Wang C, Ye Y, Hochu GM, Sadeghifar H, et al. Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett. 2016;2416:2334–2340.
   Web of Science ®Google Scholar
• Lin W, Cormier M, Samiee A. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux®) technology. Pharm res. 2001;18:1789–1793.
   PubMed Web of Science ®Google Scholar
• Hama S, Arata M, Nakamura I. Prevention of tumor growth by needle-free jet injection of anti-C7orf24 siRNA. Cancer Gene Ther. 2012;19:553
   PubMed Web of Science ®Google Scholar
• Singh BN, Singh RB, Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm. 2005;298:98.
   PubMed Web of Science ®Google Scholar
• Herai H, Gratieri T, Thomazine JA, Bentley, et al. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. Int J Pharm. 2007;329:88–93.
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Caddeo C, Vila AO, et al. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 2011;412:37–46.
   PubMed Web of Science ®Google Scholar